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Several genetic loci have been reported for psoriasis, but none has been specifically linked to psoriatic arthritis
(PsA), a condition that affects 110% of patients with psoriasis. A genetic component for PsA is suggested by
segregation within families and high concordance among identical twins. We performed a linkage scan to map
genes contributing to PsA. We identified 178 patients with PsA out of 906 patients who were included in our
genetic study of psoriasis. Using a comprehensive genealogy database, we were able to connect 100 of these into
39 families. We genotyped the patients using a framework marker set of 1,000 microsatellite markers, with an
average density of 3 cM, and performed multipoint, affected-only, allele-sharing linkage analysis using the Allegro
program. On the basis of the initial results, we genotyped more markers for the most prominent loci. A linkage
with a LOD score of 2.17 was observed on chromosome 16q. The linkage analysis, conditioned on paternal
transmission to affected individuals, gave a LOD score of 4.19, whereas a LOD score of only 1.03 was observed
when conditioned for maternal transmission. A suggestive locus on chromosome 16q has previously been implicated
in psoriasis. Our data indicate that a gene at this locus may be involved in paternal transmission of PsA.
Introduction
Psoriasis (MIM 177900) is a common inflammatory skin
disease that may have an autoimmune basis and be pre-
dominantly mediated by T lymphocytes (Baker et al.
1984; Valdimarsson et al. 1995; Prinz 1999). Several
overlapping clinical types of the disease have been iden-
tified, but the chronic plaque form (psoriasis vulgaris)
is most common and is characterized by well-demar-
cated, indurated, erythematous, and scaly lesions, or
plaques, most frequently located on knees, elbows, or
scalp. The lesions are infiltrated by inflammatory cells,
but a marked increase in proliferation and turnover of
keratinocytes distinguish psoriasis from other inflam-
matory skin diseases. The disease has a strong but com-
plex genetic basis, with a concordance rate of 50%–70%
among MZ twins (Farber et al. 1974; Eastmond 1994;
Costello and FitzGerald 2001). Several genetic loci have
been suggested, but only a major histocompatability
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(MHC) locus on chromosome 6 has been independently
reported by at least two groups as significant genome-
wide (Elder et al. 2001). Psoriasis has a strong associ-
ation with the Cw6 allele of theHLA-C gene in theMHC
(Tiilikainen et al. 1980). Accordingly, strong linkage to
the MHC region on chromosome 6p has been observed
in most populations studied (Trembath et al. 1997; Jen-
isch et al. 1998; Samuelsson et al. 1999) and has been
localized to the vicinity of HLA-C by linkage disequi-
libriummapping (Balendran et al. 1999; Oka et al. 1999;
Nair et al. 2000). Psoriatic arthritis (PsA) has been rec-
ognized since the late 19th century (Moll and Wright
1973a; Fearon and Veale 2001; Patel et al. 2001). It
affects 110% of patients with psoriasis (Gladman et al.
2001), and, in most cases, there is an association be-
tween the severity of the arthritis and the skin involve-
ment (Winchester 1995).
Several types of characteristic nail lesions are ob-
served in 35%–40% of patients with psoriasis, includ-
ing pitting, onycholysis, subungual hyperkeratosis, and
dystrophy, and it has been reported that PsA is more
common in patients with nail changes (Rahman et al.
2000). Several different types of PsA have been iden-
tified, and, in contrast to rheumatoid arthritis, most
patients with PsA are negative for rheumatoid factor
(Moll andWright 1973a). Although a clear genetic com-
ponent has been reported in PsA, with a concordance
rate range of 30%–70% among MZ twins (Moll and
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Wright 1973b; Winchester 1995), there is, to our
knowledge, no report of a genetic locus for the arthritic
manifestations of psoriasis. We have recently found that
PsA is somewhat more common in patients with HLA-
Cw6 negative than those with Cw6 positive (Gudjons-
son et al. 2002). We find that psoriatic nail lesions are
also observed more often in patients with PsA. Several
association studies dealing with the genetics of PsA that
focused on theMHC (Bruce and Silman 2001; Gladman
et al. 2001; Gonzalez et al. 2001, 2002; Al-Heresh et
al. 2002) found greater excess of one allele or another
over the Cw6 allele associated with skin psoriasis. The
association to the MHC is present in PsA, although it
is less pronounced than in the skin manifestations (East-
mond 1994; Gonzalez et al. 2002). The only other study
to attempt linkage analysis on families with PsA was
performed in a Scottish population, typing 11 micro-
satellite markers at three psoriasis loci described else-
where (Burden et al. 1998). Although a significant LOD
score was obtained for psoriasis, no evidence of linkage
was detected for PsA. A recent epidemiological study
has indicated that there are more patients suffering from
PsA who have affected fathers than have affected moth-
ers (Rahman et al. 1999). In the course of performing
linkage analysis on families with psoriasis, we observed
a locus on chromosome 16q, with linkage to PsA, that
exhibited an even higher LOD score when the study
was restricted to pairs of affected relatives in whom the
last transmission came from the father.
Subjects and Methods
This study was approved by the National Bioethics
Committee of Iceland and the Data Protection Com-
mittee of Iceland. Informed consent was obtained from
all individuals whose DNA was used in our analysis. We
used our comprehensive Icelandic genealogical database
(Gulcher and Stefansson 1998) to automatically create
families that included patients separated up to and in-
cluding seven meioses (six meioses separate second cous-
ins). All personal identifiers associated with medical in-
formation and blood samples were reversibly encrypted
by the Data Protection Committee of Iceland (Gulcher
et al. 2000). The Icelandic genealogical database was
also encrypted by the Data Protection Committee of Ice-
land (Gulcher et al. 2000).
Of 906 patients with chronic plaque psoriasis whom
we have evaluated clinically, 178 patients had been di-
agnosed with and treated for PsA by rheumatologists.
The diagnostic criteria were inflammatory arthritis, se-
ronegativity for rheumatoid factor, and unequivocal
psoriatic skin lesions at the time of diagnosis of PsA.
We genotyped these patients using a 1,000-marker fluo-
rescent labeled microsatellite screening set with an av-
erage density of 3 cM in the genome, where genetic
locations are based on the Decode map (Kong et al.
2002). Additional markers were genotyped for the
regions showing the strongest evidence for linkage, in-
creasing the density up to ∼1 cM. Genotyping was per-
formed with our standard conditions (Gretarsdottir et
al. 2002).
All reported LOD scores were calculated with Allegro
(Gudbjartsson et al. 2000). The program computes non-
parametric, multipoint, affected-only, and allele-sharing
LOD scores on the basis of the S-pairs scoring function
(Kruglyak et al. 1996) and an exponential allele-sharing
model (Kong and Cox 1997). We note that the pub-
lished Decode genetic map was originally constructed
on the basis of the Haldane map function, or a no-
interference model, but the distances were converted to
Kosambi distances in the publication to make them di-
rectly comparable with the Marshfield map (Broman et
al. 1998). However, Allegro, like many other multipoint
linkage programs, can only process a no-interference
model. Hence, our calculations here were based on the
originally estimated Haldane map, but the results are
presented with the locations converted to the published
Kosambi map to ease referencing. Positions of markers
not in the Decode map were set by interpolation on the
basis of physical distances. Families were weighted half-
way on the log scale between weighting families equally
and weighting all pairs of affected relatives equally. This
scheme gives weights similar to those proposed by
Weeks and Lange (1988) as an extension of the scheme
Hodge (1984) designed for sibships, and we have been
using it as the default (see, e.g., Gretarsdottir et al.
[2002]). Exact P values were calculated by comparing
the observed LOD score with its complete data sampling
distribution under the null hypothesis (Gudbjartsson et
al. 2000), where a linkage result is considered significant
if the single test P value is (Lander and5! 2# 10
Kruglyak 1995). We have extended our linkage analysis
program, Allegro, to include an imprinting-based scor-
ing function. The extension allows us to assign weights
to allele sharing specific to parental origins. For ex-
ample, to investigate paternal imprinting, the scoring
functions considers only the sharing of alleles trans-
mitted to two affected relatives through their fathers.
When these imprinting-based scoring functions were
used, sex-specific genetic maps (Kong et al. 2002) were
used in the calculations.
Results
The prevalence of PsA was ∼20% in our study group
(178 out of 906 patients). Using our genealogy database
and patients related to up to and including seven mei-
oses, we were able to connect 100 of these patients, 41
Karason et al.: Gene for Psoriatic Arthritis Maps to 16q 127
males (41%), and 59 females (59%), into 39 families
for linkage analysis. Of these 100 patients, 45 and 50,
respectively, were informative for linkage when pairs of
affected individuals related only through their fathers
and pairs related only through their mothers were used.
After the addition of extra markers, the strongest evi-
dence for linkage was observed on chromosome 16, with
a LOD score of 2.17 at the marker D16S3038, which
is located 75.62 cM from the p telomere of chromosome
16 (fig. 1). D16S3110, a marker we have mapped to
within 1 Mb of D16S3038, has been reported elsewhere
as marking a suggestive locus for psoriasis (Nair et al.
2000), and both of these markers are within 20 Mb of
theNOD2 gene (MIM 605956), mapped to around 60.4
cM on the Decode map, thought to confer risk for in-
flammatory bowel disease (Hugot et al. 2001; Ogura et
al. 2001). Linkage analysis using only paternal trans-
missions to affected individuals gave a maximum LOD
score of 4.19 at marker D16S267; that is, at 81.25 cM
from the p telomere of chromosome 16 or within 6 cM
of our highest linkage marker for the entire cohort (fig.
2). The exact P value for this result was 5.31#106,
which was still significant after adjustment for multiple
testing because of the three linkage scans performed. The
markers demarcating the 1-LOD drop are D16S3393
(82.7 cM from the p telomere) and D16S3089 (79.5 cM
from the p telomere). All markers used in this analysis
are available on request. When considering maternal
transmissions only, the maximum LOD score was 1.03
at marker D16S3089 (fig. 2), which we genetically
mapped to 4 cM telomeric of D16S3038, as mentioned
above. We note in our ongoing study of psoriasis, as
opposed to PsA, that there is currently no evidence for
linkage to this location (data not shown).
Discussion
Genetic imprinting in human disease, a phenomenon in-
volving a preferential paternal or maternal inheritance
of a susceptibility allele to affected individuals, has been
suggested in several complex genetic diseases (Lee et al.
2000; Cichon et al. 2001; Naumova et al. 2001; Strauch
et al. 2001; Alcolado et al. 2002; DeLisi et al. 2002;
Lindsay et al. 2002; Vandenbroeck et al. 2002) and is
well established in some rarer diseases, such as the
Prader-Willi and Angelman syndromes (Christian et al.
1998; Mann and Bartolomei 1999). Parental imprinting
has also been suggested for several complex genetic dis-
eases from an epidemiological standpoint (Lichter et al.
1995; Kato et al. 1996; Eapen et al. 1997; Haghighi et
al. 1999; Rahman et al. 1999; Meigs et al. 2000). There
is also suggestive evidence from linkage analysis, re-
ported elsewhere, of common diseases and phenotypes
where LOD scores increase or decreasewhen the analysis
is conditioned on parental transmission. These include
noninsulin-dependent diabetes mellitus, atopic derma-
titis, bipolar disease, insulin-dependent diabetes mellitus
(IDDM), schizophrenia, Crohn disease, and birth weight
(Akolkar et al. 1997; Lee et al. 2000; Meigs et al. 2000;
Cichon et al. 2001; Lindsay et al. 2001, 2002). However,
in almost all of these and other linkage scans, condi-
tioning on parental transmission, the interpretation of
the existence of imprinted disease genes, must be tem-
pered by the fact that almost none of the loci met the
criteria for statistical significance, even without correc-
tion for the testing of multiple models. Of particular
interest here is one linkage scan on psoriasis that showed
an increased paternal transmission at the MHC suscep-
tibility region (Burden et al. 1998), although we have
not observed this phenomenon for any of the loci that
we find contributing to the skin manifestations of pso-
riasis in Iceland.
Our findings support at the molecular genetic level
the recent epidemiological observation that paternal im-
printing might play a role in PsA (Rahman et al. 1999).
Reanalysis of an IDDM genome scan performed in the
United Kingdom (Mein et al. 1998) showed a paternal
inheritance factor at D16S3098, which maps to within
20 Mb of our locus on 16q, with a LOD score of 1.81
for male meioses and a LOD score of 0.33 for female
meioses at the same locus (Paterson et al. 1999). These
results are interesting, although they are far from reach-
ing statistical significance. The LOD score of 4.19 we
observe at this location, however, exceeds the accepted
criteria for genomewide significance and provides the first
indication of a location for a non-MHC gene predispos-
ing to PsA.
The position of the locus we report here is also in-
teresting considering that a locus on chromosome 16q
has been implicated in psoriasis elsewhere (Nair et al.
1997) and in Crohn disease. The Crohn disease suscep-
tibility factor consists of an insertion mutation and sev-
eral missense mutations in the NOD2 gene (which we
map to 21 cM from our highest linkage marker) that
have been identified in a subset of patients (Hugot et
al. 2001; Ogura et al. 2001). This insertion causes a
truncation of the NOD2 product that may lead to ab-
normal NF-kB responses to certain bacterial products
(Lesage et al. 2002).
It has also been reported in an epidemiological study
that the inheritance of Crohn disease may be influenced
by parental imprinting (Akolkar et al. 1997). Patients
with Crohn disease have approximately sevenfold in-
creased risk of developing psoriasis, and they are at risk
for a seronegative polyarthritis themselves (Lee et al.
1990; Nair et al. 1997), but the insertion mutation in
theNOD2 gene observed in Crohn disease has not been
found in psoriasis (Nair et al. 2001). It is possible that
other variants of the NOD2 gene may be involved in
Figure 1 Genome scan of 39 families with PsA with 1,000-microsatellite framework marker set, in addition to the fine mapping markers in all locations of interest. The multipoint LOD score
is shown on the vertical axis; the distance from the p-terminal end of the chromosome (in cM) is shown on the horizontal axis.
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Figure 2 Linkage result of 39 families on chromosome 16 with additional markers and considering paternal transmissions only (black
line) and maternal transmissions only (red line). The multipoint LOD score is shown on the vertical axis; the distance from the p-terminal end
of the chromosome (in cM) is shown on the horizontal axis.
psoriasis or a gene that is closely linked to NOD2. Our
PsA cohort has not been screened for the known mu-
tations in the NOD2 gene.
The peak we observe on chromosome 16 overlaps
with a peak we have observed in families with osteo-
arthritis (OA) (data not shown). It is also, therefore,
possible that what we are observing is a gene that causes
susceptibility to joint afflictions. On the one hand, it
may lead to OA when other susceptibility factors
(trauma or other genetic factors) are present, and on
the other hand, it may lead to PsA when factors pre-
disposing to psoriasis are present. Our study shows the
importance of the ability to link large numbers of pa-
tients together as we have done using our genealogy
database. Additionally, looking at parental effects on
the inheritance of phenotypes may add a new dimension
to previous or future linkage scans, as we have found
in this case.
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